Maryland, 22 March 2023: The US Food and Drug Administration has expanded the indicated age range for evinacumab-dgnb (Evkeeza, Regeneron Pharmaceuticals), which was approved 2 years ago as an adjunct to other lipid-l......
View Details

Related News

• If Hyperprolactinaemia caused by Esomeprazole, report to the NCC-PvPI, IPC (04-10-2023)

---

• Youth arrested with 600 intoxicating pills (04-10-2023)

---

• Fake degree racket busted in Bulandshahr, 3 held (04-10-2023)

---

• 1.5 Lakh Banned Tablets worth Rs 30 lakh recovered, case registered against couple under NDPS Act (04-10-2023)

---

• MDC recommends exemption for Panacea Biotec's EasyFourPoI vaccine from DPCO (04-10-2023)

---

• Nanded hospital deaths expose Maharashtra’s flawed medicine procurement system (04-10-2023)

---

• Mumbai: NCB seizes 1.840 kg of Alprazolam, 9,696 bottles of banned cough syrups; four held (04-10-2023)

---

• 200 Medical Device producers barred by new law, applications not approved (04-10-2023)

---

• Fatehgarh Police arrested 5 drug smugglers with 2.30 lakh pills and other items (03-10-2023)

---

• ICMR urges scientists to develop accurate typhoid test (03-10-2023)

---